⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

Official Title: A Randomized, Open-Label, Multicenter, Phase II Trial Evaluating the Safety and Activity of Pinatuzumab Vedotin (DCDT2980S) in Combination With Rituximab or Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab and a Non-Randomized Phase Ib/II Evaluation of Polatuzumab Vedotin in Combination With Obinutuzumab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Study ID: NCT01691898

Study Description

Brief Summary: This multicenter, open-label study will evaluate the safety and efficacy of pinatuzumab vedotin (DCDT2980S) or polatuzumab vedotin (DCDS4501A) in combination with rituximab (RTX), as well as of polatuzumab vedotin in combination with obinutuzumab in participants with relapsed or refractory (r/r) follicular lymphoma (FL) and r/r diffuse large B-cell lymphoma (DLBCL).

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Cedars-Sinai Medical Center, Los Angeles, California, United States

Stanford Cancer Center, Stanford, California, United States

Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center, Denver, Colorado, United States

Georgetown University Medical Center Lombardi Cancer Center, Washington, District of Columbia, United States

Florida Cancer Specialists - Fort Myers (Colonial Center Dr), Fort Myers, Florida, United States

Florida Cancer Specialists; Sarasota, Sarasota, Florida, United States

Univ of Michigan Med School; Hematology Oncology, Ann Arbor, Michigan, United States

Comprehensive Cancer Centers of Nevada - Eastern Avenue, Las Vegas, Nevada, United States

Hematology Oncology Associates; Carol G. Simon Ctr, Morristown, New Jersey, United States

Regional Cancer Care Associates LLC - Morristown, Morristown, New Jersey, United States

Roswell Park Cancer Inst., Buffalo, New York, United States

New York University Cancer Cen, New York, New York, United States

Oncology Hematology Care Inc, Cincinnati, Ohio, United States

Willamette Valley Cancer Ctr - 520 Country Club, Eugene, Oregon, United States

Oregon Health Sciences Uni, Portland, Oregon, United States

Sarah Cannon Cancer Center - Tennessee Oncology, Pllc, Nashville, Tennessee, United States

Texas Oncology-Baylor Sammons Cancer Center, Dallas, Texas, United States

Cancer Care Centers of South Texas, San Antonio, Texas, United States

Texas Transplant Inst., San Antonio, Texas, United States

Texas Oncology, P.A. - Tyler; Tyler Cancer Center, Tyler, Texas, United States

Fairfax N Virginia Hem/Onc PC, Fairfax, Virginia, United States

Oncology & Hematolgy Associates of SW Va Inc. - Roanoke, Roanoke, Virginia, United States

Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Northwest Cancer Specialists - Vancouver, Vancouver, Washington, United States

Yakima Valley Memorial Hospital/North Star Lodge, Yakima, Washington, United States

Univ of Wisconsin-Madison, Madison, Wisconsin, United States

Cross Cancer Institute, Edmonton, Alberta, Canada

British Columbia Cancer Agency, Vancouver, British Columbia, Canada

McGill University; Sir Mortimer B Davis Jewish General Hospital; Oncology, Montreal, Quebec, Canada

Hopital Claude Huriez - CHU Lille, Lille, , France

CHU Montpellier - Saint ELOI, Montpellier, , France

Hopital Saint Louis ; Service d Oncologie Medicale Fougere 6 (Pr Misset), Paris, , France

Centre Hospitalier Lyon Sud, Pierre Benite, , France

Centre Henri Becquerel; Hematologie, Rouen, , France

Uniklinik Heidelberg, Medizinische Klinik & Poliklinik V, Heidelberg, , Germany

Universitätsmedizin Johannes Gutenberg Universität; Klinik u. Poliklinik f. Neurologie, Mainz, , Germany

Klinikum d.Universität München Campus Großhadern, München, , Germany

A.O. Universitaria Policlinico S.Orsola-Malpighi Di Bologna, Bologna, Emilia-Romagna, Italy

Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2, Milano, Lombardia, Italy

Azienda Ospedale San Giovanni, Torino, Piemonte, Italy

Academisch Medisch Centrum; Hematologie, Amsterdam, , Netherlands

Contact Details

Name: Clinical Trials

Affiliation: Genentech, Inc.

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: